Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002652462 | SCV003532997 | uncertain significance | Inborn genetic diseases | 2021-08-13 | criteria provided, single submitter | clinical testing | The c.1422C>A (p.D474E) alteration is located in exon 10 (coding exon 10) of the GLE1 gene. This alteration results from a C to A substitution at nucleotide position 1422, causing the aspartic acid (D) at amino acid position 474 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004695336 | SCV005190992 | uncertain significance | not provided | criteria provided, single submitter | not provided |